Real World Evidence 2013 from June 6-7 in Bethesda, MD will host more great panel discussions like this!
Please fill in your information in the adjacent form to be the first to receive a detailed 8 page brochure
Just a taste of what we'll be covering at the event:
- Pharma case studies from Sanofi, Pfizer, Boehringer Ingelheim, Johnson & Johnson, and Merck that tell stories of why real-world evidence is a real world opportunity in drug development strategy.
- Policy Perspectives from the Senate Health Committee, HHS, NIH, and ASPE.
- Payers reveal why they are interested in collaborating with Pharma on the evidence generated about the real-world effects of medical treatments - from Aetna and more.
- Providers give insight on how they are adapting to efficiently capture patient data - from Penn Medical, Tufts & CT Center for Primary Care.
Please fill in your information in the adjacent form to be the first to receive the detailed 8 page brochure
"A good networking & learning opportunity on topics essential for healthcare improvement. This meeting has global experts willing to share the spirit of open innovation. The panel discussions offer valuable insights with relevant and pragmatic content."
Tehseen Salimi, VP Global Evidence and Value Development, Sanofi